ECRM_1170x120_8-1-17

Diplomat Pharmacy

Diplomat works to control specialty drug costs

Diplomat works to control specialty drug costs

FLINT, Mich. — Biosimilars, generic drugs and affordable branded drugs are top-of-mind at Diplomat Pharmacy Inc. this year as the specialty pharmacy looks to help health plans and patients rein in costs. According to Diplomat president Joel Saban, the surging market for expensive specialty drugs has put pressure on stakeholders across the health care sector.

Diplomat CEO Phil Hagerman to retire

Diplomat CEO Phil Hagerman to retire

FLINT, Mich. — Phil Hagerman, co-founder, chairman and chief executive officer of Diplomat Pharmacy Inc., the nation’s largest independent specialty pharmacy, plans to retire. Diplomat said Friday that board member Jeff Park has been named interim CEO, and independent lead director Ben Wolin has been appointed chairman. Both moves are effective immediately. Diplomat’s board has launched

Diplomat wraps up acquisition of LDI

Diplomat wraps up acquisition of LDI

FLINT, Mich. — Diplomat Pharmacy Inc. has closed its $595 million acquisition of pharmacy benefit manager LDI Integrated Pharmacy Services. With the completion of the cash-and-stock deal, Diplomat also announced that it has obtained $800 million in senior secured credit facilities. The proceeds of the debt financing will be used to finance the LDI acquisition, pay related transaction fees and

Analysts size up Amazon’s pharmacy opportunity

Analysts size up Amazon’s pharmacy opportunity

NEW YORK — Pharmacy stands as a sizable growth opportunity for Amazon, and its avenues for market entry include acquisitions, with Rite Aid Corp. and Diplomat Pharmacy Inc. among potential targets, according to Cowen analysts John Blackledge and Charles Rhyee. Cowen on Tuesday released an in-depth look at a potential Amazon pharmacy play in a

Peters appointed sales EVP at Diplomat

FLINT, Mich. — Robyn Peters has joined Diplomat Pharmacy in the role of executive vice president of sales and payor strategies. Peters, most recently vice president of market access and reimbursement at Biogen Inc., will oversee Diplomat’s payor and business development strategies, along with sales and pharma account management, and become a member of the

Diplomat Pharmacy buys LDI for $595 million

Diplomat Pharmacy buys LDI for $595 million

FLINT, Mich. — Diplomat Pharmacy Inc. plans to acquire St. Louis-based pharmacy benefit manager LDI Integrated Pharmacy Services for in a $595 million cash and stock deal. The move marks the second PBM acquisition this month by Diplomat, the nation’s largest independent specialty pharmacy. On Nov. 6, the company announced the purchase of National Pharmacy

Diplomat tabs former Biogen, Walgreens exec as EVP

Diplomat tabs former Biogen, Walgreens exec as EVP

FLINT, Mich. — Robyn Peters has joined Diplomat Pharmacy Inc. as executive vice president of sales and payor strategies. Peters, most recently vice president of market access and reimbursement at Biogen Inc., will oversee Diplomat’s payor and business development strategies, along with sales and pharma account management, and become a member of the specialty pharmacy’s executive

Diplomat purchases software company

FLINT, Mich. — Diplomat Pharmacy Inc. has acquired 8th Day Software and Consulting LLC. With the purchase, the specialty pharmacy also appointed 8th Day Software founder and chief executive officer Dave Loschinskey as Diplomat’s chief information officer. Loschinskey has served as CEO of 8th Day since launching the firm in 2013. The acquisition calls for

Diplomat acquires 8th Day Software

Diplomat acquires 8th Day Software

FLINT, Mich. — Diplomat Pharmacy Inc. has acquired 8th Day Software and Consulting LLC, appointing its founder and chief executive officer Dave Loschinskey as Diplomat chief information officer. Financial terms of the transaction weren’t disclosed. Plans call for 8th Day Software, based in Cordova, Tenn., to operate under Diplomat subsidiary Envoy Health Management LLC. The specialty

Diplomat Pharmacy acquires Focus Rx

Diplomat Pharmacy acquires Focus Rx

FLINT, Mich. — Diplomat Pharmacy Inc. has purchased specialty and infusion pharmacy Focus Rx Pharmacy Services Inc. Financial terms of the transaction weren’t disclosed. Long Island, N.Y.-based Focus Rx has locations in Holbrook and Ronkonkoma, N.Y., where it’s headquartered. With a strong patient focus, Focus Rx provides home infusion and specialty prescription management services and,

Saban to succeed Urick as Diplomat president

FLINT, Mich. — Diplomat Pharmacy recently announced the appointment of Joel Saban as the new company president. Paul Urick has decided to pursue other interests and will serve as president emeritus during a planned 90-day transition period. “During his tenure, Paul has served us in multiple leadership roles since he joined Diplomat with the acquisition

Diplomat starts dispensing naloxone without Rx

Diplomat starts dispensing naloxone without Rx

FLINT, Mich. — Diplomat Pharmacy Inc. has begun providing naloxone, an antidote for opioid overdose, to Michigan residents. Diplomat said late Tuesday that naloxone is available without a prescription at its retail pharmacy in Flint, Mich. “Protecting the health and safety of our patients is what we do,” Gary Rice, executive vice president of operations

Joel Saban tabbed as Diplomat Pharmacy president

Joel Saban tabbed as Diplomat Pharmacy president

FLINT, Mich. — Diplomat Pharmacy Inc. has named Joel Saban as president, taking over from Paul Urick, who’s leaving the company to pursue other interests. The nation’s largest independent specialty pharmacy said late Monday that Urick will serve as president emeritus during a 90-day transition period. Saban had served as executive vice president of pharmacy

Diplomat acquires WRB Communications

Diplomat acquires WRB Communications

FLINT, Mich. — Diplomat Pharmacy Inc. has acquired WRB Communications Inc., a Chantilly, Va.-based operator of health care contact centers, in a $29 million deal. Under the agreement, announced late Monday, Diplomat is paying WRB $24.5 million in cash and $4.5 million in common stock. Plans call for WRB to join Diplomat’s Envoy Health Management

1 2 3 4